safety of retatrutide The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide for Women: Safety, Results

Zepbound Savings Card 2026: Limits & Restrictions The Zepbound Savings Card is a manufacturer-sponsored program with specific terms: Saves up to $100 per monthly fill Maximum benefit: $1,300 per calendar year (resets January 1) Limited to 13 fills per calendar year Valid only for patients with commercial (private) insurance not Medicare, Medicaid, or TRICARE Card expires December 31, 2026 Cannot be combined with GoodRx or other third-party discount cards No coupon codes exist for Zepbound savings come exclusively through Eli Lillys official programs

Statins are the benchmark: the Cholesterol Treatment Trialists' meta-analysis (~170,000 patients, ~5-year follow-up) shows every 1 mmol/L drop in LDL cuts major vascular events by about 21% and all-cause mortality by about 10%

Al-Gadani, Y., El-Ansary, A., Attas, O., & Al-Ayadhi, L

Leachables and Extractables Testing Every material in contact with the nasal spray drug product the HDPE bottle, the polypropylene pump housing, the elastomeric valve gaskets and seals, the actuator tip, and any metal spring components is a potential source of extractable compounds that may migrate into the drug product during manufacture, storage, and use

New insights into molecular mechanisms mediating adaptation to exercise